Attached is a really interesting though somewhat long at 30 minutes video  (Published on Oct 22, 2013), on the emerging role of genomics in the management of newly diagnosed low risk PC.

Dr. Denes discusses the PIVOT study, PSA testing yes or no, and then goes into a discussion on genomics testing as a factor in a decision whether to continue on active surveillance or seek further treatment

It is a really clear and lucid presentation which I think anyone who has been recently diagnosed or those who are on active surveillance would benefit from listening to.

View Video

Leave a Comment

Scroll to Top